Takeda UK Limited

5 employees

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Investor insights

Sectors invested in

Biotechnology74

Health Care51

Therapeutics38

Pharmaceutical26

Medical23

Life Science15

Biopharma12

Immuno-Oncology7

Medical Device6

Immunotherapy6

Information Technology5

Clinical Trials4

Drug Discovery4

Infectious diseases4

Genetics3

oncology3

Chemical2

Neurology2

Translation Enhancers2

Rare Disease2

Funding rounds participated in

$2.5M sweet spot round size

Most of their 87 investments are in rounds between $15M and $65M

Investor type

Corporate Venture Capital

Basic info

Industry

venture capital and private equity principals

Sectors

Emphasis on Oncology

Health Diagnostics

Neuroscience

Financial Services

Finance

Therapeutics

Collaborative Interactions that result in Synergies with Takeda's considerable R&D Resources.

Gastroenterology

Rare Diseases

Build a Portfolio of Strategic Investments

Date founded

2001

Investments made

Larkspur Biosciences raised $36M on May 23, 2023

Investors: 3E Bioventures Capital, Polaris Partners and Takeda UK Limited

OncoResponse Inc. raised $14M on May 18, 2023

Investors: RiverVest Venture Partners, INTERVEST-Mortgage Investment Co., 3B Future Health Fund, Canaan, ARCH Venture Partners, Bering Capital and Takeda UK Limited

Cerevance raised $51M on February 13, 2023

Investors: Dolby Family Ventures, The Dementia Discovery Fund, GV, Foresite Capital, Lightstone Ventures, UPMC Enterprises and Takeda UK Limited

Ensoma raised $85M on January 5, 2023

Investors: Qatar Investment Authority, Mirae Asset MAPS Global Investments Co., Ltd, fred hutch, Viking Global Investors, F-Prime Capital Partners, Catalio Capital Management, -, Solasta Ventures and Takeda UK Limited

hC Bioscience, Inc. raised $16M on November 4, 2022

Investors: ARCH Venture Partners, 8VC and Takeda UK Limited

Enzyre B.V. raised $12M on November 2, 2022

Investors: Advanced Endoscopy, i&i Biotech Fund, Oost NL, Novalis_Fund and Takeda UK Limited

Zelluna Immunotherapy raised undisclosed on August 25, 2022

Investors: Takeda UK Limited

Be Biopharma raised $130M on April 14, 2022

Investors: Alta Partners, Bristol-Myers Squibb, UK, ARCH Venture Partners, Longwood Fund, Atlas Venture, RA Capital Management, L.P. and Takeda UK Limited

hC Bioscience, Inc. raised $24M on February 23, 2022

Investors: ARCH Venture Partners, 8VC and Takeda UK Limited

Koneksa raised $45M on February 7, 2022

Investors: Waterline Ventures, dRx data, Spring Mountain Capital and Takeda UK Limited